According to YH Research, the global market for Premature Ejaculation Treatment Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Premature Ejaculation Treatment Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Premature Ejaculation Treatment Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Under 25 Years Old grew percent to account for percent of the total market sales, and 25 to 40 Years Old grew percent.
This report studies and analyses global Premature Ejaculation Treatment Drug status and future trends, to help determine the Premature Ejaculation Treatment Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Premature Ejaculation Treatment Drug, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Premature Ejaculation Treatment Drug market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Premature Ejaculation Treatment Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Premature Ejaculation Treatment Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Premature Ejaculation Treatment Drug key consuming regions, consumption value and demand structure
(5) Premature Ejaculation Treatment Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Absorption Pharmaceuticals
AstraZeneca
Allergan, Plc
Bayer AG
Eli Lilly & Company
GlaxoSmithkline, Plc
Innovus Pharmaceutical
Merck & Co., Inc.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
Market segment by Type, covers
Selective Serotonin Reuptake Inhibitor
Tricyclic Antidepressant
Topical Anesthetic Agent
Phosphodiesterase 5 Inhibitors
Others
Market segment by Application, can be divided into
Under 25 Years Old
25 to 40 Years Old
40 to 55 years old
Over 55 Years Old
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Premature Ejaculation Treatment Drug product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Premature Ejaculation Treatment Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Premature Ejaculation Treatment Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Premature Ejaculation Treatment Drug industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Premature Ejaculation Treatment Drug Definition
1.2 Global Premature Ejaculation Treatment Drug Market Size and Forecast
1.3 China Premature Ejaculation Treatment Drug Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Premature Ejaculation Treatment Drug Market Size: China VS Global Growth Rate, 2018-2029
1.6 Premature Ejaculation Treatment Drug Market Dynamics
1.6.1 Premature Ejaculation Treatment Drug Market Drivers
1.6.2 Premature Ejaculation Treatment Drug Market Restraints
1.6.3 Premature Ejaculation Treatment Drug Industry Trends
1.6.4 Premature Ejaculation Treatment Drug Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Premature Ejaculation Treatment Drug, Global Market Share by Company, 2018-2023
2.2 Global Premature Ejaculation Treatment Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Premature Ejaculation Treatment Drug Concentration Ratio
2.4 Global Premature Ejaculation Treatment Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Premature Ejaculation Treatment Drug Major Companies Product Type
2.6 Head Office and Premature Ejaculation Treatment Drug Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Premature Ejaculation Treatment Drug, China Market Share by Company, 2018-2023
3.2 China Premature Ejaculation Treatment Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Premature Ejaculation Treatment Drug Industry Chain
4.2 Premature Ejaculation Treatment Drug Upstream Analysis
4.2.1 Premature Ejaculation Treatment Drug Core Raw Materials
4.2.2 Main Manufacturers of Premature Ejaculation Treatment Drug Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Premature Ejaculation Treatment Drug Production Mode
4.6 Premature Ejaculation Treatment Drug Procurement Model
4.7 Premature Ejaculation Treatment Drug Industry Sales Model and Sales Channels
4.7.1 Premature Ejaculation Treatment Drug Sales Model
4.7.2 Premature Ejaculation Treatment Drug Typical Distributors
5 Sights by Type
5.1 Premature Ejaculation Treatment Drug Classification
5.1.1 Selective Serotonin Reuptake Inhibitor
5.1.2 Tricyclic Antidepressant
5.1.3 Topical Anesthetic Agent
5.1.4 Phosphodiesterase 5 Inhibitors
5.1.5 Others
5.2 By Type, Global Premature Ejaculation Treatment Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Premature Ejaculation Treatment Drug Consumption Value, 2018-2029
6 Sights by Application
6.1 Premature Ejaculation Treatment Drug Segment by Application
6.1.1 Under 25 Years Old
6.1.2 25 to 40 Years Old
6.1.3 40 to 55 years old
6.1.4 Over 55 Years Old
6.2 By Application, Global Premature Ejaculation Treatment Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Premature Ejaculation Treatment Drug Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Premature Ejaculation Treatment Drug Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Premature Ejaculation Treatment Drug Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Premature Ejaculation Treatment Drug & Forecasts, 2018-2029
7.3.2 By Country, North America Premature Ejaculation Treatment Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Premature Ejaculation Treatment Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Premature Ejaculation Treatment Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Premature Ejaculation Treatment Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Premature Ejaculation Treatment Drug Market Size Market Share
7.6 South America
7.6.1 South America Premature Ejaculation Treatment Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Premature Ejaculation Treatment Drug Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Premature Ejaculation Treatment Drug Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Premature Ejaculation Treatment Drug Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Premature Ejaculation Treatment Drug Market Size, 2018-2029
8.3.2 By Type, U.S. Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Premature Ejaculation Treatment Drug Market Size, 2018-2029
8.4.2 By Type, Europe Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Premature Ejaculation Treatment Drug Market Size, 2018-2029
8.5.2 By Type, China Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Premature Ejaculation Treatment Drug Market Size, 2018-2029
8.6.2 By Type, Japan Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Premature Ejaculation Treatment Drug Market Size, 2018-2029
8.7.2 By Type, South Korea Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Premature Ejaculation Treatment Drug Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Premature Ejaculation Treatment Drug Market Size, 2018-2029
8.9.2 By Type, India Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Premature Ejaculation Treatment Drug Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Absorption Pharmaceuticals
9.1.1 Absorption Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.1.2 Absorption Pharmaceuticals Company Profile and Main Business
9.1.3 Absorption Pharmaceuticals Premature Ejaculation Treatment Drug Models, Specifications and Application
9.1.4 Absorption Pharmaceuticals Premature Ejaculation Treatment Drug Revenue and Gross Margin, 2018-2023
9.1.5 Absorption Pharmaceuticals Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
9.2.2 AstraZeneca Company Profile and Main Business
9.2.3 AstraZeneca Premature Ejaculation Treatment Drug Models, Specifications and Application
9.2.4 AstraZeneca Premature Ejaculation Treatment Drug Revenue and Gross Margin, 2018-2023
9.2.5 AstraZeneca Recent Developments
9.3 Allergan, Plc
9.3.1 Allergan, Plc Company Information, Head Office, Market Area and Industry Position
9.3.2 Allergan, Plc Company Profile and Main Business
9.3.3 Allergan, Plc Premature Ejaculation Treatment Drug Models, Specifications and Application
9.3.4 Allergan, Plc Premature Ejaculation Treatment Drug Revenue and Gross Margin, 2018-2023
9.3.5 Allergan, Plc Recent Developments
9.4 Bayer AG
9.4.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
9.4.2 Bayer AG Company Profile and Main Business
9.4.3 Bayer AG Premature Ejaculation Treatment Drug Models, Specifications and Application
9.4.4 Bayer AG Premature Ejaculation Treatment Drug Revenue and Gross Margin, 2018-2023
9.4.5 Bayer AG Recent Developments
9.5 Eli Lilly & Company
9.5.1 Eli Lilly & Company Company Information, Head Office, Market Area and Industry Position
9.5.2 Eli Lilly & Company Company Profile and Main Business
9.5.3 Eli Lilly & Company Premature Ejaculation Treatment Drug Models, Specifications and Application
9.5.4 Eli Lilly & Company Premature Ejaculation Treatment Drug Revenue and Gross Margin, 2018-2023
9.5.5 Eli Lilly & Company Recent Developments
9.6 GlaxoSmithkline, Plc
9.6.1 GlaxoSmithkline, Plc Company Information, Head Office, Market Area and Industry Position
9.6.2 GlaxoSmithkline, Plc Company Profile and Main Business
9.6.3 GlaxoSmithkline, Plc Premature Ejaculation Treatment Drug Models, Specifications and Application
9.6.4 GlaxoSmithkline, Plc Premature Ejaculation Treatment Drug Revenue and Gross Margin, 2018-2023
9.6.5 GlaxoSmithkline, Plc Recent Developments
9.7 Innovus Pharmaceutical
9.7.1 Innovus Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.7.2 Innovus Pharmaceutical Company Profile and Main Business
9.7.3 Innovus Pharmaceutical Premature Ejaculation Treatment Drug Models, Specifications and Application
9.7.4 Innovus Pharmaceutical Premature Ejaculation Treatment Drug Revenue and Gross Margin, 2018-2023
9.7.5 Innovus Pharmaceutical Recent Developments
9.8 Merck & Co., Inc.
9.8.1 Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position
9.8.2 Merck & Co., Inc. Company Profile and Main Business
9.8.3 Merck & Co., Inc. Premature Ejaculation Treatment Drug Models, Specifications and Application
9.8.4 Merck & Co., Inc. Premature Ejaculation Treatment Drug Revenue and Gross Margin, 2018-2023
9.8.5 Merck & Co., Inc. Recent Developments
9.9 Pfizer, Inc.
9.9.1 Pfizer, Inc. Company Information, Head Office, Market Area and Industry Position
9.9.2 Pfizer, Inc. Company Profile and Main Business
9.9.3 Pfizer, Inc. Premature Ejaculation Treatment Drug Models, Specifications and Application
9.9.4 Pfizer, Inc. Premature Ejaculation Treatment Drug Revenue and Gross Margin, 2018-2023
9.9.5 Pfizer, Inc. Recent Developments
9.10 Teva Pharmaceutical Industries Ltd.
9.10.1 Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
9.10.2 Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
9.10.3 Teva Pharmaceutical Industries Ltd. Premature Ejaculation Treatment Drug Models, Specifications and Application
9.10.4 Teva Pharmaceutical Industries Ltd. Premature Ejaculation Treatment Drug Revenue and Gross Margin, 2018-2023
9.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. Premature Ejaculation Treatment Drug Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Premature Ejaculation Treatment Drug Market Restraints
Table 3. Premature Ejaculation Treatment Drug Market Trends
Table 4. Premature Ejaculation Treatment Drug Industry Policy
Table 5. Global Premature Ejaculation Treatment Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Premature Ejaculation Treatment Drug Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Premature Ejaculation Treatment Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Premature Ejaculation Treatment Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Premature Ejaculation Treatment Drug Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Premature Ejaculation Treatment Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Premature Ejaculation Treatment Drug Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Premature Ejaculation Treatment Drug Upstream (Raw Materials)
Table 14. Global Premature Ejaculation Treatment Drug Typical Customers
Table 15. Premature Ejaculation Treatment Drug Typical Distributors
Table 16. By Type, Global Premature Ejaculation Treatment Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Premature Ejaculation Treatment Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Premature Ejaculation Treatment Drug Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Premature Ejaculation Treatment Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Premature Ejaculation Treatment Drug Consumption Value Market Share, 2018-2029
Table 23. Absorption Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 24. Absorption Pharmaceuticals Company Profile and Main Business
Table 25. Absorption Pharmaceuticals Premature Ejaculation Treatment Drug Models, Specifications, and Application
Table 26. Absorption Pharmaceuticals Premature Ejaculation Treatment Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Absorption Pharmaceuticals Recent Developments
Table 28. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 29. AstraZeneca Company Profile and Main Business
Table 30. AstraZeneca Premature Ejaculation Treatment Drug Models, Specifications, and Application
Table 31. AstraZeneca Premature Ejaculation Treatment Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. AstraZeneca Recent Developments
Table 33. Allergan, Plc Company Information, Head Office, Market Area and Industry Position
Table 34. Allergan, Plc Company Profile and Main Business
Table 35. Allergan, Plc Premature Ejaculation Treatment Drug Models, Specifications, and Application
Table 36. Allergan, Plc Premature Ejaculation Treatment Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Allergan, Plc Recent Developments
Table 38. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 39. Bayer AG Company Profile and Main Business
Table 40. Bayer AG Premature Ejaculation Treatment Drug Models, Specifications, and Application
Table 41. Bayer AG Premature Ejaculation Treatment Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Bayer AG Recent Developments
Table 43. Eli Lilly & Company Company Information, Head Office, Market Area and Industry Position
Table 44. Eli Lilly & Company Company Profile and Main Business
Table 45. Eli Lilly & Company Premature Ejaculation Treatment Drug Models, Specifications, and Application
Table 46. Eli Lilly & Company Premature Ejaculation Treatment Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Eli Lilly & Company Recent Developments
Table 48. GlaxoSmithkline, Plc Company Information, Head Office, Market Area and Industry Position
Table 49. GlaxoSmithkline, Plc Company Profile and Main Business
Table 50. GlaxoSmithkline, Plc Premature Ejaculation Treatment Drug Models, Specifications, and Application
Table 51. GlaxoSmithkline, Plc Premature Ejaculation Treatment Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. GlaxoSmithkline, Plc Recent Developments
Table 53. Innovus Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 54. Innovus Pharmaceutical Company Profile and Main Business
Table 55. Innovus Pharmaceutical Premature Ejaculation Treatment Drug Models, Specifications, and Application
Table 56. Innovus Pharmaceutical Premature Ejaculation Treatment Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Innovus Pharmaceutical Recent Developments
Table 58. Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position
Table 59. Merck & Co., Inc. Company Profile and Main Business
Table 60. Merck & Co., Inc. Premature Ejaculation Treatment Drug Models, Specifications, and Application
Table 61. Merck & Co., Inc. Premature Ejaculation Treatment Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Merck & Co., Inc. Recent Developments
Table 63. Pfizer, Inc. Company Information, Head Office, Market Area and Industry Position
Table 64. Pfizer, Inc. Company Profile and Main Business
Table 65. Pfizer, Inc. Premature Ejaculation Treatment Drug Models, Specifications, and Application
Table 66. Pfizer, Inc. Premature Ejaculation Treatment Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Pfizer, Inc. Recent Developments
Table 68. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
Table 69. Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
Table 70. Teva Pharmaceutical Industries Ltd. Premature Ejaculation Treatment Drug Models, Specifications, and Application
Table 71. Teva Pharmaceutical Industries Ltd. Premature Ejaculation Treatment Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Teva Pharmaceutical Industries Ltd. Recent Developments
List of Figures
Figure 1. Premature Ejaculation Treatment Drug Picture
Figure 2. Global Premature Ejaculation Treatment Drug Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Premature Ejaculation Treatment Drug Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Premature Ejaculation Treatment Drug Market Share of Global, 2018-2029
Figure 5. Global Premature Ejaculation Treatment Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Premature Ejaculation Treatment Drug Key Participants, Market Share, 2022
Figure 7. Premature Ejaculation Treatment Drug Industry Chain
Figure 8. Premature Ejaculation Treatment Drug Procurement Model
Figure 9. Premature Ejaculation Treatment Drug Sales Model
Figure 10. Premature Ejaculation Treatment Drug Sales Channels, Direct Sales, and Distribution
Figure 11. Selective Serotonin Reuptake Inhibitor
Figure 12. Tricyclic Antidepressant
Figure 13. Topical Anesthetic Agent
Figure 14. Phosphodiesterase 5 Inhibitors
Figure 15. Others
Figure 16. By Type, Global Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Figure 17. By Type, Global Premature Ejaculation Treatment Drug Consumption Value Market Share, 2018-2029
Figure 18. Under 25 Years Old
Figure 19. 25 to 40 Years Old
Figure 20. 40 to 55 years old
Figure 21. Over 55 Years Old
Figure 22. By Application, Global Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Figure 23. By Application, Global Premature Ejaculation Treatment Drug Consumption Value Market Share, 2018-2029
Figure 24. By Region, Global Premature Ejaculation Treatment Drug Consumption Value Market Share, 2018-2029
Figure 25. North America Premature Ejaculation Treatment Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, North America Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022
Figure 27. Europe Premature Ejaculation Treatment Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, Europe Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022
Figure 29. Asia Pacific Premature Ejaculation Treatment Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 30. By Country/Region, Asia Pacific Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022
Figure 31. South America Premature Ejaculation Treatment Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 32. By Country, South America Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022
Figure 33. Middle East & Africa Premature Ejaculation Treatment Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 34. U.S. Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Figure 35. By Type, U.S. Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 36. By Application, U.S. Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 37. Europe Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Figure 38. By Type, Europe Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 39. By Application, Europe Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 40. China Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Figure 41. By Type, China Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 42. By Application, China Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 43. Japan Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Figure 44. By Type, Japan Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 45. By Application, Japan Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 46. South Korea Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Figure 47. By Type, South Korea Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 48. By Application, South Korea Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 49. Southeast Asia Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Figure 50. By Type, Southeast Asia Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 51. By Application, Southeast Asia Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 52. India Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Figure 53. By Type, India Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 54. By Application, India Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 55. Middle East & Africa Premature Ejaculation Treatment Drug Consumption Value, 2018-2029, US$ Million
Figure 56. By Type, Middle East & Africa Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 57. By Application, Middle East & Africa Premature Ejaculation Treatment Drug Consumption Value Market Share, 2022 VS 2029
Figure 58. Research Methodology
Figure 59. Breakdown of Primary Interviews
Figure 60. Bottom-up and Top-down Approaches
Figure 61. Top-down Approaches
Reason to Buy